Dr. Hönle Stock Forecast for 2023 - 2025 - 2030

Updated on 05/02/2024

Stock Rating
15
Price Target
29.15€
Consensus
Outperform
Upside
46.85%
Analysts
0
Stock Rating
15
Upside
46.85%
Analysts
0
Price Target
29.15€

Dr. Hönle Stock Forecast and Price Target

Dr. Hönle's stock is projected to advance by 46.85% from the previous closing price if it reaches the average target of 29.15€ by the year's end, as reputable analysts recently projected. This potential upside is calculated on a high-end estimate of 29.30€ and a low-end estimate of 29.00€. Even if you are not interested in HNL stock, you should still be aware of its competitors.

29.15€

46.85% Upside

Buy
Buy

Dr. Hönle Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Dr. Hönle's Price has decreased from 29.60€ to 0.00€ – a 100.00% drop. Next year, analysts are expecting Fair Value to reach 32.16€ – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
32.16€
2025 Fair Value Forecast
49.52€
2026 Fair Value Forecast
43.73€
2027 Fair Value Forecast
25.97€
2028 Fair Value Forecast
30.00€
2029 Fair Value Forecast
36.82€
2030 Fair Value Forecast
41.29€

Dr. Hönle Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Dr. Hönle's Revenue has grown from 93.90€M to 106.40€M – a 13.31% increase. Next year, analysts are expecting Revenue to reach 117.75€M – an increase of 10.67%. Over the next seven years, the forecast is for Revenue to grow by 65.60%.

2024 Rev Forecast
0.12€B
2025 Rev Forecast
0.13€B
2026 Rev Forecast
0.14€B
2027 Rev Forecast
0.15€B
2028 Rev Forecast
0.16€B
2029 Rev Forecast
0.17€B
2030 Rev Forecast
0.18€B

Dr. Hönle Dividend per Share Forecast for 2023 - 2025 - 2030

Dr. Hönle's Dividend per Share has decreased by 60.00% In the last year, from 0.50€ to 0.20€. For next year, analysts predict Dividend per Share of 0.25€, which would mean an increase of 25.00%. Over the next seven years, experts predict that Dr. Hönle's Dividend per Share will grow at a rate of 154.62%.

2024 DPS Forecast
0.25€
2025 DPS Forecast
0.50€
2026 DPS Forecast
0.63€
2027 DPS Forecast
0.44€
2028 DPS Forecast
0.40€
2029 DPS Forecast
0.44€
2030 DPS Forecast
0.51€

Dr. Hönle Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
0.01€B
2025 FCF Forecast
0.01€B
2026 FCF Forecast
0.01€B
2027 FCF Forecast
0.01€B
2028 FCF Forecast
0.01€B
2029 FCF Forecast
0.01€B
2030 FCF Forecast
0.01€B

Dr. Hönle EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Dr. Hönle has seen a decline in its EBITDA, from 11.96€M to 10.58€M – a 11.54% decrease. In the next year, analysts believe that EBITDA will reach 18.40€M – an increase of 73.91%. For the next seven years, the forecast is for EBITDA to grow by 57.90%.

2024 EBITDA Forecast
0.02€B
2025 EBITDA Forecast
0.02€B
2026 EBITDA Forecast
0.01€B
2027 EBITDA Forecast
0.01€B
2028 EBITDA Forecast
0.02€B
2029 EBITDA Forecast
0.02€B
2030 EBITDA Forecast
0.02€B

Dr. Hönle EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Dr. Hönle's EBIT has decreased by 27.93%, from 8.63€M to 6.22€M. In the next year, analysts believe that EBIT will reach 11.10€M – an increase of 78.46%. For the next seven years, experts predict that Dr. Hönle's EBIT will grow at a rate of 324.44%.

2024 EBIT Forecast
0.01€B
2025 EBIT Forecast
0.02€B
2026 EBIT Forecast
0.02€B
2027 EBIT Forecast
0.02€B
2028 EBIT Forecast
0.02€B
2029 EBIT Forecast
0.03€B
2030 EBIT Forecast
0.03€B

Dr. Hönle EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Dr. Hönle's EPS has decreased from 1.04€ to 0.00€ – a 100.00% drop. Next year, analysts are expecting EPS to reach 1.13€ – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
1.13€
2025 EPS Forecast
1.74€
2026 EPS Forecast
1.54€
2027 EPS Forecast
0.91€
2028 EPS Forecast
1.05€
2029 EPS Forecast
1.29€
2030 EPS Forecast
1.45€